Clinical Trial: Colostrum from MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06857318) titled 'Colostrum from MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.' on Feb. 27.

Brief Summary: The study aims to study the efficacy of colostrum from MERS-CoV-positive camels applied as a nasal spray to COVID-19 patients for treatment and prevention of SARS-CoV-2 infection. This study will compare the usage of colostrum to placebo.

Study Start Date: May 01, 2023

Study Type: INTERVENTIONAL

Condition: COVID 19

Intervention: BIOLOGICAL: Colostrum Nasal Spray

24 hours use of nasal spray of colostrum from MERS-CoV positive camels- 6 doses total

OTHER: Water for injection

24 hours use of...